Orion Genomics Licenses IP from Johns Hopkins for Early Colorectal Cancer Test

Jun 11, 2008

This article has been updated from an earlier version to clarify the fact that the proposed test would be for prognostic, not diagnostic, use.

NEW YORK (GenomeWeb News) – Orion Genomics has licensed exclusive, worldwide rights from the Johns Hopkins University to a gene that it plans to use in a test for early prognosis of colorectal cancer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Marks Left on the Genome

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

Cost and Coverage of Gene Therapies

The Wall Street Journal looks into the cost of new gene therapies.

Mosquito Population Crash

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

This Week in PNAS

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Main menu